Specialty Drug Distribution-United States Market Status and Trend Report 2013-2023
Report Summary
Specialty Drug Distribution-United States Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Specialty Drug Distribution industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole United States and Regional Market Size of Specialty Drug Distribution 2013-2017, and development forecast 2018-2023
Main market players of Specialty Drug Distribution in United States, with company and product introduction, position in the Specialty Drug Distribution market
Market status and development trend of Specialty Drug Distribution by types and applications
Cost and profit status of Specialty Drug Distribution, and marketing status
Market growth drivers and challenges
The report segments the United States Specialty Drug Distribution market as:
United States Specialty Drug Distribution Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
New England
The Middle Atlantic
The Midwest
The West
The South
Southwest
United States Specialty Drug Distribution Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Oncology
Rheumatoid Arthritis
Multiple Sclerosis
Hemophilia
Other
United States Specialty Drug Distribution Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Retail
Home Health
Clinics
Pharmacies
United States Specialty Drug Distribution Market: Players Segment Analysis (Company and Product introduction, Specialty Drug Distribution Sales Volume, Revenue, Price and Gross Margin):
Amerisource
Mckesson
Cardinal Health
PHOENIX
Medipal Holdings
Alliance Healthcare
Celesio
Sinopharm
Accredo
Shanghai Pharma
Anda
Jointown
Max Pharma
Avella
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Specialty Drug Distribution-United States Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Specialty Drug Distribution industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole United States and Regional Market Size of Specialty Drug Distribution 2013-2017, and development forecast 2018-2023
Main market players of Specialty Drug Distribution in United States, with company and product introduction, position in the Specialty Drug Distribution market
Market status and development trend of Specialty Drug Distribution by types and applications
Cost and profit status of Specialty Drug Distribution, and marketing status
Market growth drivers and challenges
The report segments the United States Specialty Drug Distribution market as:
United States Specialty Drug Distribution Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
New England
The Middle Atlantic
The Midwest
The West
The South
Southwest
United States Specialty Drug Distribution Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Oncology
Rheumatoid Arthritis
Multiple Sclerosis
Hemophilia
Other
United States Specialty Drug Distribution Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Retail
Home Health
Clinics
Pharmacies
United States Specialty Drug Distribution Market: Players Segment Analysis (Company and Product introduction, Specialty Drug Distribution Sales Volume, Revenue, Price and Gross Margin):
Amerisource
Mckesson
Cardinal Health
PHOENIX
Medipal Holdings
Alliance Healthcare
Celesio
Sinopharm
Accredo
Shanghai Pharma
Anda
Jointown
Max Pharma
Avella
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF SPECIALTY DRUG DISTRIBUTION
1.1 Definition of Specialty Drug Distribution in This Report
1.2 Commercial Types of Specialty Drug Distribution
1.2.1 Oncology
1.2.2 Rheumatoid Arthritis
1.2.3 Multiple Sclerosis
1.2.4 Hemophilia
1.2.5 Other
1.3 Downstream Application of Specialty Drug Distribution
1.3.1 Retail
1.3.2 Home Health
1.3.3 Clinics
1.3.4 Pharmacies
1.4 Development History of Specialty Drug Distribution
1.5 Market Status and Trend of Specialty Drug Distribution 2013-2023
1.5.1 United States Specialty Drug Distribution Market Status and Trend 2013-2023
1.5.2 Regional Specialty Drug Distribution Market Status and Trend 2013-2023
CHAPTER 2 UNITED STATES MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Specialty Drug Distribution in United States 2013-2017
2.2 Consumption Market of Specialty Drug Distribution in United States by Regions
2.2.1 Consumption Volume of Specialty Drug Distribution in United States by Regions
2.2.2 Revenue of Specialty Drug Distribution in United States by Regions
2.3 Market Analysis of Specialty Drug Distribution in United States by Regions
2.3.1 Market Analysis of Specialty Drug Distribution in New England 2013-2017
2.3.2 Market Analysis of Specialty Drug Distribution in The Middle Atlantic 2013-2017
2.3.3 Market Analysis of Specialty Drug Distribution in The Midwest 2013-2017
2.3.4 Market Analysis of Specialty Drug Distribution in The West 2013-2017
2.3.5 Market Analysis of Specialty Drug Distribution in The South 2013-2017
2.3.6 Market Analysis of Specialty Drug Distribution in Southwest 2013-2017
2.4 Market Development Forecast of Specialty Drug Distribution in United States 2018-2023
2.4.1 Market Development Forecast of Specialty Drug Distribution in United States 2018-2023
2.4.2 Market Development Forecast of Specialty Drug Distribution by Regions 2018-2023
CHAPTER 3 UNITED STATES MARKET STATUS AND FORECAST BY TYPES
3.1 Whole United States Market Status by Types
3.1.1 Consumption Volume of Specialty Drug Distribution in United States by Types
3.1.2 Revenue of Specialty Drug Distribution in United States by Types
3.2 United States Market Status by Types in Major Countries
3.2.1 Market Status by Types in New England
3.2.2 Market Status by Types in The Middle Atlantic
3.2.3 Market Status by Types in The Midwest
3.2.4 Market Status by Types in The West
3.2.5 Market Status by Types in The South
3.2.6 Market Status by Types in Southwest
3.3 Market Forecast of Specialty Drug Distribution in United States by Types
CHAPTER 4 UNITED STATES MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Specialty Drug Distribution in United States by Downstream Industry
4.2 Demand Volume of Specialty Drug Distribution by Downstream Industry in Major Countries
4.2.1 Demand Volume of Specialty Drug Distribution by Downstream Industry in New England
4.2.2 Demand Volume of Specialty Drug Distribution by Downstream Industry in The Middle Atlantic
4.2.3 Demand Volume of Specialty Drug Distribution by Downstream Industry in The Midwest
4.2.4 Demand Volume of Specialty Drug Distribution by Downstream Industry in The West
4.2.5 Demand Volume of Specialty Drug Distribution by Downstream Industry in The South
4.2.6 Demand Volume of Specialty Drug Distribution by Downstream Industry in Southwest
4.3 Market Forecast of Specialty Drug Distribution in United States by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF SPECIALTY DRUG DISTRIBUTION
5.1 United States Economy Situation and Trend Overview
5.2 Specialty Drug Distribution Downstream Industry Situation and Trend Overview
CHAPTER 6 SPECIALTY DRUG DISTRIBUTION MARKET COMPETITION STATUS BY MAJOR PLAYERS IN UNITED STATES
6.1 Sales Volume of Specialty Drug Distribution in United States by Major Players
6.2 Revenue of Specialty Drug Distribution in United States by Major Players
6.3 Basic Information of Specialty Drug Distribution by Major Players
6.3.1 Headquarters Location and Established Time of Specialty Drug Distribution Major Players
6.3.2 Employees and Revenue Level of Specialty Drug Distribution Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 SPECIALTY DRUG DISTRIBUTION MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Amerisource
7.1.1 Company profile
7.1.2 Representative Specialty Drug Distribution Product
7.1.3 Specialty Drug Distribution Sales, Revenue, Price and Gross Margin of Amerisource
7.2 Mckesson
7.2.1 Company profile
7.2.2 Representative Specialty Drug Distribution Product
7.2.3 Specialty Drug Distribution Sales, Revenue, Price and Gross Margin of Mckesson
7.3 Cardinal Health
7.3.1 Company profile
7.3.2 Representative Specialty Drug Distribution Product
7.3.3 Specialty Drug Distribution Sales, Revenue, Price and Gross Margin of Cardinal Health
7.4 PHOENIX
7.4.1 Company profile
7.4.2 Representative Specialty Drug Distribution Product
7.4.3 Specialty Drug Distribution Sales, Revenue, Price and Gross Margin of PHOENIX
7.5 Medipal Holdings
7.5.1 Company profile
7.5.2 Representative Specialty Drug Distribution Product
7.5.3 Specialty Drug Distribution Sales, Revenue, Price and Gross Margin of Medipal Holdings
7.6 Alliance Healthcare
7.6.1 Company profile
7.6.2 Representative Specialty Drug Distribution Product
7.6.3 Specialty Drug Distribution Sales, Revenue, Price and Gross Margin of Alliance Healthcare
7.7 Celesio
7.7.1 Company profile
7.7.2 Representative Specialty Drug Distribution Product
7.7.3 Specialty Drug Distribution Sales, Revenue, Price and Gross Margin of Celesio
7.8 Sinopharm
7.8.1 Company profile
7.8.2 Representative Specialty Drug Distribution Product
7.8.3 Specialty Drug Distribution Sales, Revenue, Price and Gross Margin of Sinopharm
7.9 Accredo
7.9.1 Company profile
7.9.2 Representative Specialty Drug Distribution Product
7.9.3 Specialty Drug Distribution Sales, Revenue, Price and Gross Margin of Accredo
7.10 Shanghai Pharma
7.10.1 Company profile
7.10.2 Representative Specialty Drug Distribution Product
7.10.3 Specialty Drug Distribution Sales, Revenue, Price and Gross Margin of Shanghai Pharma
7.11 Anda
7.11.1 Company profile
7.11.2 Representative Specialty Drug Distribution Product
7.11.3 Specialty Drug Distribution Sales, Revenue, Price and Gross Margin of Anda
7.12 Jointown
7.12.1 Company profile
7.12.2 Representative Specialty Drug Distribution Product
7.12.3 Specialty Drug Distribution Sales, Revenue, Price and Gross Margin of Jointown
7.13 Max Pharma
7.13.1 Company profile
7.13.2 Representative Specialty Drug Distribution Product
7.13.3 Specialty Drug Distribution Sales, Revenue, Price and Gross Margin of Max Pharma
7.14 Avella
7.14.1 Company profile
7.14.2 Representative Specialty Drug Distribution Product
7.14.3 Specialty Drug Distribution Sales, Revenue, Price and Gross Margin of Avella
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF SPECIALTY DRUG DISTRIBUTION
8.1 Industry Chain of Specialty Drug Distribution
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF SPECIALTY DRUG DISTRIBUTION
9.1 Cost Structure Analysis of Specialty Drug Distribution
9.2 Raw Materials Cost Analysis of Specialty Drug Distribution
9.3 Labor Cost Analysis of Specialty Drug Distribution
9.4 Manufacturing Expenses Analysis of Specialty Drug Distribution
CHAPTER 10 MARKETING STATUS ANALYSIS OF SPECIALTY DRUG DISTRIBUTION
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Specialty Drug Distribution in This Report
1.2 Commercial Types of Specialty Drug Distribution
1.2.1 Oncology
1.2.2 Rheumatoid Arthritis
1.2.3 Multiple Sclerosis
1.2.4 Hemophilia
1.2.5 Other
1.3 Downstream Application of Specialty Drug Distribution
1.3.1 Retail
1.3.2 Home Health
1.3.3 Clinics
1.3.4 Pharmacies
1.4 Development History of Specialty Drug Distribution
1.5 Market Status and Trend of Specialty Drug Distribution 2013-2023
1.5.1 United States Specialty Drug Distribution Market Status and Trend 2013-2023
1.5.2 Regional Specialty Drug Distribution Market Status and Trend 2013-2023
CHAPTER 2 UNITED STATES MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Specialty Drug Distribution in United States 2013-2017
2.2 Consumption Market of Specialty Drug Distribution in United States by Regions
2.2.1 Consumption Volume of Specialty Drug Distribution in United States by Regions
2.2.2 Revenue of Specialty Drug Distribution in United States by Regions
2.3 Market Analysis of Specialty Drug Distribution in United States by Regions
2.3.1 Market Analysis of Specialty Drug Distribution in New England 2013-2017
2.3.2 Market Analysis of Specialty Drug Distribution in The Middle Atlantic 2013-2017
2.3.3 Market Analysis of Specialty Drug Distribution in The Midwest 2013-2017
2.3.4 Market Analysis of Specialty Drug Distribution in The West 2013-2017
2.3.5 Market Analysis of Specialty Drug Distribution in The South 2013-2017
2.3.6 Market Analysis of Specialty Drug Distribution in Southwest 2013-2017
2.4 Market Development Forecast of Specialty Drug Distribution in United States 2018-2023
2.4.1 Market Development Forecast of Specialty Drug Distribution in United States 2018-2023
2.4.2 Market Development Forecast of Specialty Drug Distribution by Regions 2018-2023
CHAPTER 3 UNITED STATES MARKET STATUS AND FORECAST BY TYPES
3.1 Whole United States Market Status by Types
3.1.1 Consumption Volume of Specialty Drug Distribution in United States by Types
3.1.2 Revenue of Specialty Drug Distribution in United States by Types
3.2 United States Market Status by Types in Major Countries
3.2.1 Market Status by Types in New England
3.2.2 Market Status by Types in The Middle Atlantic
3.2.3 Market Status by Types in The Midwest
3.2.4 Market Status by Types in The West
3.2.5 Market Status by Types in The South
3.2.6 Market Status by Types in Southwest
3.3 Market Forecast of Specialty Drug Distribution in United States by Types
CHAPTER 4 UNITED STATES MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Specialty Drug Distribution in United States by Downstream Industry
4.2 Demand Volume of Specialty Drug Distribution by Downstream Industry in Major Countries
4.2.1 Demand Volume of Specialty Drug Distribution by Downstream Industry in New England
4.2.2 Demand Volume of Specialty Drug Distribution by Downstream Industry in The Middle Atlantic
4.2.3 Demand Volume of Specialty Drug Distribution by Downstream Industry in The Midwest
4.2.4 Demand Volume of Specialty Drug Distribution by Downstream Industry in The West
4.2.5 Demand Volume of Specialty Drug Distribution by Downstream Industry in The South
4.2.6 Demand Volume of Specialty Drug Distribution by Downstream Industry in Southwest
4.3 Market Forecast of Specialty Drug Distribution in United States by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF SPECIALTY DRUG DISTRIBUTION
5.1 United States Economy Situation and Trend Overview
5.2 Specialty Drug Distribution Downstream Industry Situation and Trend Overview
CHAPTER 6 SPECIALTY DRUG DISTRIBUTION MARKET COMPETITION STATUS BY MAJOR PLAYERS IN UNITED STATES
6.1 Sales Volume of Specialty Drug Distribution in United States by Major Players
6.2 Revenue of Specialty Drug Distribution in United States by Major Players
6.3 Basic Information of Specialty Drug Distribution by Major Players
6.3.1 Headquarters Location and Established Time of Specialty Drug Distribution Major Players
6.3.2 Employees and Revenue Level of Specialty Drug Distribution Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 SPECIALTY DRUG DISTRIBUTION MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Amerisource
7.1.1 Company profile
7.1.2 Representative Specialty Drug Distribution Product
7.1.3 Specialty Drug Distribution Sales, Revenue, Price and Gross Margin of Amerisource
7.2 Mckesson
7.2.1 Company profile
7.2.2 Representative Specialty Drug Distribution Product
7.2.3 Specialty Drug Distribution Sales, Revenue, Price and Gross Margin of Mckesson
7.3 Cardinal Health
7.3.1 Company profile
7.3.2 Representative Specialty Drug Distribution Product
7.3.3 Specialty Drug Distribution Sales, Revenue, Price and Gross Margin of Cardinal Health
7.4 PHOENIX
7.4.1 Company profile
7.4.2 Representative Specialty Drug Distribution Product
7.4.3 Specialty Drug Distribution Sales, Revenue, Price and Gross Margin of PHOENIX
7.5 Medipal Holdings
7.5.1 Company profile
7.5.2 Representative Specialty Drug Distribution Product
7.5.3 Specialty Drug Distribution Sales, Revenue, Price and Gross Margin of Medipal Holdings
7.6 Alliance Healthcare
7.6.1 Company profile
7.6.2 Representative Specialty Drug Distribution Product
7.6.3 Specialty Drug Distribution Sales, Revenue, Price and Gross Margin of Alliance Healthcare
7.7 Celesio
7.7.1 Company profile
7.7.2 Representative Specialty Drug Distribution Product
7.7.3 Specialty Drug Distribution Sales, Revenue, Price and Gross Margin of Celesio
7.8 Sinopharm
7.8.1 Company profile
7.8.2 Representative Specialty Drug Distribution Product
7.8.3 Specialty Drug Distribution Sales, Revenue, Price and Gross Margin of Sinopharm
7.9 Accredo
7.9.1 Company profile
7.9.2 Representative Specialty Drug Distribution Product
7.9.3 Specialty Drug Distribution Sales, Revenue, Price and Gross Margin of Accredo
7.10 Shanghai Pharma
7.10.1 Company profile
7.10.2 Representative Specialty Drug Distribution Product
7.10.3 Specialty Drug Distribution Sales, Revenue, Price and Gross Margin of Shanghai Pharma
7.11 Anda
7.11.1 Company profile
7.11.2 Representative Specialty Drug Distribution Product
7.11.3 Specialty Drug Distribution Sales, Revenue, Price and Gross Margin of Anda
7.12 Jointown
7.12.1 Company profile
7.12.2 Representative Specialty Drug Distribution Product
7.12.3 Specialty Drug Distribution Sales, Revenue, Price and Gross Margin of Jointown
7.13 Max Pharma
7.13.1 Company profile
7.13.2 Representative Specialty Drug Distribution Product
7.13.3 Specialty Drug Distribution Sales, Revenue, Price and Gross Margin of Max Pharma
7.14 Avella
7.14.1 Company profile
7.14.2 Representative Specialty Drug Distribution Product
7.14.3 Specialty Drug Distribution Sales, Revenue, Price and Gross Margin of Avella
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF SPECIALTY DRUG DISTRIBUTION
8.1 Industry Chain of Specialty Drug Distribution
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF SPECIALTY DRUG DISTRIBUTION
9.1 Cost Structure Analysis of Specialty Drug Distribution
9.2 Raw Materials Cost Analysis of Specialty Drug Distribution
9.3 Labor Cost Analysis of Specialty Drug Distribution
9.4 Manufacturing Expenses Analysis of Specialty Drug Distribution
CHAPTER 10 MARKETING STATUS ANALYSIS OF SPECIALTY DRUG DISTRIBUTION
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
